Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(21/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(21/week)
News
United States
(626/week)
Manufacturing
(444/week)
Energy
(347/week)
Technology
(486/week)
Other Manufacturing
(371/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Alnylam Pharmaceuticals
Dec 03, 2020
PANTHERx Rare® Pharmacy Chosen as Partner by Alnylam Pharmaceuticals for OXLUMO(TM) (lumasiran) for the Treatment of Primary Hyperoxaluria Type 1 (PH1) to Lower Urinary Oxalate Levels
Dec 03, 2020
Orsini Specialty Pharmacy Expands Partnership With Alnylam® Pharmaceuticals As A Limited Distribution Partner For OXLUMO(TM) (lumasiran)
May 18, 2020
Infectious Diseases Partnering Terms and Agreements, 2014 to 2020
Feb 11, 2020
NORD Introduces This Year's Rare Disease-Fighting Super Group: The 2020 Rare Impact Award Honorees!
Dec 12, 2019
PANTHERx® Rare Pharmacy Selected by Alnylam Pharmaceuticals to Distribute GIVLAARI(TM) (givosiran)
Oct 14, 2019
Global RNA Interference (RNAi) Industry
Sep 24, 2019
Obsidian Therapeutics Appoints Erin Boyer as Vice President, Human Resources
Aug 13, 2019
RNAi Technologies Market 2019, Industry Analysis, Competitors Strategy, Trends and Demands, Key Applications, Forecast To 2025
Aug 07, 2019
Ionis Reports Second Quarter 2019 Financial Results
Jul 23, 2019
Alnylam Launches ONPATTRO® (patisiran) for the Treatment of Polyneuropathy in hATTR Amyloidosis, the First-Ever RNAi Therapeutic Approved in Canada
Apr 26, 2019
Sanofi delivers strong Q1 2019 business EPS growth of 9.4% at CER
Apr 08, 2019
Regeneron and Alnylam Announce Broad Collaboration to Discover, Develop and Commercialize RNAi Therapeutics Focused on Ocular and Central Nervous System (CNS) Diseases
Nov 19, 2018
Amyloidosis Treatment Market Worth $6.7 Billion by 2025 | CAGR: 7.2%: Grand View Research, Inc.
Nov 13, 2018
Global $6.7 Billion Amyloidosis Treatment Market to 2023 - Key Players are Alnylam, Ionis, Pfizer, Johnson & Johnson and Takeda
Oct 29, 2018
Invitae expands work with Alnylam Pharmaceuticals to provide access to genetic testing for primary hyperoxaluria
Oct 03, 2018
Kessler Topaz Meltzer & Check, LLP: Securities Fraud Class Action Filed Against Alnylam Pharmaceuticals, Inc. - ALNY
Sep 27, 2018
ALNYLAM CLASS ACTION LAWSUIT: BERNSTEIN LIEBHARD LLP ANNOUNCES THAT A SECURITIES CLASS ACTION LAWSUIT HAS BEEN FILED AGAINST ALNYLAM PHARMACEUTICALS, INC. - ALNY
Sep 27, 2018
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Alnylam Pharmaceuticals, Inc. (ALNY) and Lead Plaintiff Deadline - November 26, 2018
Sep 27, 2018
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Alnylam Pharmaceuticals, Inc. To Contact The Firm
Aug 27, 2018
RNA-based Therapeutics and Vaccines Market is Expected to be Account US$ 632.06 Mn By 2026: Persistence Market Research
Page 1
››
Latest News
May 5, 2024
Teijin Automotive Technologies Celebrates Opening of Huntington, Indiana, Facility Expansion
May 4, 2024
Berkshire Hathaway Inc. First Quarter 2024 Earnings Release
May 4, 2024
How to Prevent Heatstroke at Your Business with Airrex and PortaCool.
May 4, 2024
Kolibri Global Energy Inc. Revocation of Management Cease Trade Order
May 4, 2024
Anaergia Announces Additional Delay in the Filing of Its Audited Financial Statements and Related Disclosures
May 4, 2024
Electriq Power Holdings, Inc. Announces Chapter 7 Bankruptcy Filing
May 4, 2024
Atos: les créanciers et les banques ont fait une offre commune de refinancement
May 4, 2024
OSI Systems President and CEO Deepak Chopra to Retire by Calendar Year-End, Will Remain as Executive Chairman
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events